Drug profile · INN
rimantadine hydrochloride
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride (RIMANTADINE HYDROCHLORIDE) is a influenza virus a matrix protein m2 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — rimantadine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
rimantadine hydrochloride (RIMANTADINE HYDROCHLORIDE) is a influenza virus a matrix protein m2 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Influenza virus A matrix protein M2 inhibitor
Primary target: Matrix protein 2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is rimantadine hydrochloride?
rimantadine hydrochloride (RIMANTADINE HYDROCHLORIDE) is a influenza virus a matrix protein m2 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rimantadine hydrochloride?
RIMANTADINE HYDROCHLORIDE is a marketed brand name for rimantadine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rimantadine hydrochloride?
rimantadine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.